Document is current
Any future updates will be listed below
-
Authors
Makin, Ryan D.
Apicella, Ivana
Dholkawala, Roshni
Fukuda, Shinichi
Hirahara, Shuichiro
Hirano, Yoshio
Kim, Younghee
Nagasaka, Ayami
Nagasaka, Yosuke
Narendran, Siddharth
Pereira, Felipe
Varshney, Akhil
Wang, Shao-bin
Ambati, Jayakrishna
Gelfand, Bradley D.
-
Funding
Funding for this research was provided by:
National Eye Institute (R01EY031039, R01EY031039)
National Institute on Aging (R01AG082108, R01AG082108)
National Heart, Lung, and Blood Institute (R01HL164592)
- License Information
-
More Information
Article History
Received: 23 February 2024
Accepted: 13 September 2024
First Online: 24 September 2024
Declarations
:
: J.A: co-founder of DiceRx, iVeena Holdings, iVeena Delivery Systems and Inflammasome Therapeutics, and, unrelated to this work, has been a consultant for Abbvie/Allergan, Boehringer-Ingelheim, Janssen, Olix Pharmaceuticals, Retinal Solutions, and Saksin LifeSciences. B.D.G: co-founder of DiceRx. J.A., S.W., B.D.G.: inventors on matter-related patent applications filed by the University of Virginia or Kentucky.
